Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001853529-25-000003

Chief Scientific Officer sold 100,000 shares at $14.60 ($1,459,760)

  • Chief Scientific Officer acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Russell Alan J · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-26 Exercise or conversion : show line 1 in the form +100,000 $0.18 $18,000 123,400 D
2025-08-26 Sale : show line 2 in the form −100,000 $14.60 $1,459,760 23,400 D
Open-market sales · 100,000 sh · avg $14.60 · $1,459,760

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-26 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −100,000 1,247,365 D
Loading xslF345X05/primarydocument.xml…